Compare United Airlines Holdings Inc (UAL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Airlines Holdings Inc vs Zimmer Biomet Holdings Inc — how do they compare? United Airlines Holdings Inc trades at $107.32 (market cap $34.87B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: United Airlines Holdings Inc is far larger — about 2.1× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold United Airlines Holdings Inc for 46 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| UAL | ZBH | |
|---|---|---|
Market Cap | $34.87B | $16.95B |
Volume | 6,329,678 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $136.11 | $103.98 |
52-Week Low | $85.21 | $79.58 |
Typical Hold Time | 46 Days | 89 Days |
Enterprise Value | $51.90B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
United Airlines (UAL) trades at $107.46, down 2.46% with a bearish technical signal despite strong fundamentals. The stock shows attractive valuation metrics with P/E of 10.1 and P/S of 0.6, supported by consistent earnings beats and improving profitability. Recent news highlights aggressive customer acquisition strategies targeting Delta's premium travelers through status-match offers and Starlink-enabled WiFi advantages.
UAL presents a compelling value opportunity with analyst consensus price target of $158.10 (47% upside) and unanimous buy/hold ratings. However, near-term headwinds include rising fuel costs, labor expenses, and technical weakness. The company's strong cash flow generation and strategic positioning for premium customer capture support long-term growth prospects despite current market pessimism.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
